4 ASX growth shares to buy to supercharge your portfolio in June

Analysts think these exciting growth stocks are in the buy zone.

| More on:
A fit man flexes his muscles, indicating a positive share price movement on the ASX market

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add some growth shares to your investment portfolio in June?

If you are, then the four highly rated ASX growth shares listed below could be worth considering.

Here's what you need to know about them:

Aristocrat Leisure Limited (ASX: ALL)

The first ASX growth share that could be a buy is Aristocrat Leisure. It is one of the world's leading gaming technology companies. It has a world class portfolio of pokie machines, a lucrative digital business, and a growing real money gaming business.

Analysts at Citi are very positive on the company. Particularly given its strong performance in the first half of FY 2024 and management's confidence in its outlook.

Citi has a buy rating and a $53.00 price target on Aristocrat Leisure's shares.

Pro Medicus Limited (ASX: PME)

Goldman Sachs thinks Pro Medicus is a top ASX growth share to buy. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Goldman is very positive on the company's outlook. It notes that it sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

The broker has a buy rating and a $136.00 price target on its shares.

ResMed Inc. (ASX: RMD)

A third ASX growth share that has been tipped as a buy is ResMed. It is a sleep treatment-focused medical device company.

ResMed has been growing at a strong rate for over a decade. But if you thought its growth was coming to an end, think again. That's because its industry-leading products have a massive market opportunity. Management estimates that there are 1 billion people impacted by sleep apnoea worldwide, with only ~20% of these sufferers currently diagnosed.

Ord Minnett is bullish on ResMed and has an accumulate rating and a $40.00 price target on its shares.

TechnologyOne Ltd (ASX: TNE)

A final ASX growth share for investors to look at in June is TechnologyOne. It is Australia's largest enterprise software company with locations across six countries. It provides a global SaaS ERP solution that transforms business and makes life simple for users.

Analysts at Morgans were impressed with the company's half-year results this month. In fact, the broker believes that the company's profit growth is about to go up a gear. Particularly given its successful transition to a software-as-a-service business model.

Morgans currently has an add rating and a $20.50 price target on its shares.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Pro Medicus, ResMed, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Pro Medicus, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Five young people sit in a row having fun and interacting with their mobile phones.
Growth Shares

7 excellent ASX growth shares to buy next week

Analysts think growth investors should be buying these stocks.

Read more »

Man waiting for his flight and looking at his phone.
Growth Shares

Near its 52-week low, this ASX growth stock could be the bargain of the year!

I think this stock could be a leading opportunity.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

2 top ASX growth shares to buy today and hold for 10 years

Analysts are very bullish on the outlooks of these buy-rated shares.

Read more »

Person handing out $100 notes, symbolising ex-dividend date.
Growth Shares

What are the best ASX shares to buy with $500 in 2024?

Analysts are bullish on these shares for good reason. Let's find out why.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Growth Shares

5 top ASX growth shares to buy in June

Analysts think growth investors should be snapping up these stocks while they can.

Read more »

A man holding a packaging box with a recycle symbol on it gives the thumbs up.
Industrials Shares

This ASX growth stock just leapt 6% on international expansion plans

The ASX growth stock is shrugging off the broader market malaise on Monday.

Read more »

A woman shows her phone screen and points up.
Growth Shares

1 ASX share on the cusp of profitability

This growth stock is rocketing towards positive financials.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Analysts say these 5 ASX 200 growth shares are top buys

These stocks could be great options for growth investors this month.

Read more »